Trials / Unknown
UnknownNCT01535534
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
Evaluation of Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Universitätsmedizin Mannheim · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
During the past years many investigators have focused on the immunological changes in sepsis disease, and great attention has been paid to the development of practicable means of immunomonitoring. Little is known about diagnostic and prognostic vascular biomarkers during the time course of patients with sepsis.
Detailed description
Primary Outcome Measures: New diagnostic and prognostic markers for septic patients Estimated Enrollment: 300 patients Study Start Date: January 2012 Estimated Study Completion Date: open Estimated Primary Completion Date: open Intervention Details: Procedure: vein puncture comparison of different inflammatory markers in the blood of septic patients
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2018-12-01
- Completion
- 2021-12-01
- First posted
- 2012-02-17
- Last updated
- 2020-08-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01535534. Inclusion in this directory is not an endorsement.